Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 37 - Drugs for immunological or allergic disorders
Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
08/2003
08/28/2003CA2476452A1 Electroporation methods for introducing bioactive agents into cells
08/28/2003CA2476434A1 Method of treating trx mediated diseases
08/28/2003CA2476406A1 Fused pyridazine derivative compounds and drugs containing the compounds as the active ingredient
08/28/2003CA2476112A1 Rna interference mediated inhibition of interleukin gene expression using short interfering nucleic acid (sina)
08/28/2003CA2475879A1 Synthesis of quinazolinones
08/28/2003CA2475437A1 Methods for producing .gamma..delta. t cells
08/28/2003CA2474848A1 Novel tyloindicines and related processes, pharmaceutical compositions and methods
08/28/2003CA2473100A1 Pyranones useful as atm inhibitors
08/28/2003CA2473089A1 Piperidin-4-yl urea derivatives and related compounds as chemokine receptor inhibitors for the treatment of inflammatory diseases
08/28/2003CA2473078A1 Method for producing interferon
08/28/2003CA2463595A1 Rna interference mediated inhibition of bcl2 gene expression using short interfering nucleic acid (sina)
08/28/2003CA2463438A1 Antipruritics
08/28/2003CA2459532A1 Rna interference by modified short interfering nucleic acid
08/27/2003EP1337636A2 Soluble zcytor 11 cytokine receptors
08/27/2003EP1337634A2 Novel polypeptides involved in immune response
08/27/2003EP1337560A2 Truncated cd200
08/27/2003EP1337544A2 Polynucleotide encoding an activated human t-lymphocyte-derived protein related to ubiquitin conjugating enzyme
08/27/2003EP1337527A1 Indolylmaleimide derivatives as protein kinase c inhibitors
08/27/2003EP1337521A1 Salts of an isothiazole-4-carboxamide and their use as anti-hyperproliferation agents
08/27/2003EP1337512A1 (4-acylaminopiperidin-1-yl) acetamides as neurokinin antagonists
08/27/2003EP1337269A2 Association of calpain inhibitors and reactive oxygen species trapping agents
08/27/2003EP1337268A1 Use of bromelain for the treatment of inflammatory diseases and for adjuvant therapy during wound healing processes
08/27/2003EP1337256A2 Use of thienopyrimidines
08/27/2003EP1267834A4 Cationic liposomes
08/27/2003EP1183047B1 Pharmaceutical preparation
08/27/2003EP1143920B1 Oil-in-water emulsion comprising a micronised biologically active agent and an appropriate emulsifier system
08/27/2003EP1124577B1 USE OF AN ENTEROBACTERIUM PROTEIN OmpA FOR SPECIFIC TARGETING TOWARDS ANTIGEN-PRESENTING CELLS
08/27/2003EP1095039B1 New pharmaceutically active compounds
08/27/2003EP1061951B1 Use of skin penetration enhancers and barrier disruption agents to enhance the transcutaneous immune response induced by adp-ribosylating exotoxin
08/27/2003EP1036794B1 2-aryl-8-oxodihydropurine derivatives, process for producing the same, medicinal compositions containing the same, and intermediates thereof
08/27/2003EP0862552B1 Succinimide and maleimide cytokine inhibitors
08/27/2003EP0760685B1 Thiolation of proteins for radionuclide-based radioimmunodetection and radioimmunotherapy
08/27/2003EP0750458B1 Terminal complement inhibitor fusion genes and proteins
08/27/2003CN1439022A Human monoclonal antibody against a costimulatory signal transduction molecule AILIM and pharmaceutical use thereof
08/27/2003CN1439021A Parathyroid hormone and parathyroid hormone-related protein receptor modulators
08/27/2003CN1439017A Novel compounds
08/27/2003CN1439010A Pyrrolo [2,3-d] pyrimidine compounds as immunosuppressive agents
08/27/2003CN1439009A Imidazo pyrimidine derivatives and triazolopyrimidine derivatives
08/27/2003CN1439005A Pyrrole substituted 2-indolinone protein kinase inhibitors
08/27/2003CN1439003A Arylmethy lamine derivatives for use as tryptase inhibitors
08/27/2003CN1439001A Tetrahydropyridino or piperidino hetlrocyclic derivatives
08/27/2003CN1438894A Methods for regulating a cell-mediated immune response by blocking lymphocytic signals and by blocking LFA-1 medicated adhesion
08/27/2003CN1438891A Nucleoside analogs with carboxamidine wodified monocyclic base
08/27/2003CN1438890A 腺苷受体调制剂 Adenosine receptor modulators
08/27/2003CN1438244A Self-body immunity-disease related egg-yolk atibody preparation method and use thereof
08/27/2003CN1438220A 1-(1,2-disubstituted piperidyl)-4-substituted diethylenediamine derivative
08/27/2003CN1119346C Benzothiadiaxoles and derivatives
08/27/2003CN1119340C Carbamyloxy compounds which inhibit leukocyte adhesion mediated by VLA-4
08/27/2003CN1119328C Acylaminoalkenylene-amide derivatives as NK1 and NK2 antagonists
08/27/2003CN1119158C Youth and longevity pellet and its preparation
08/27/2003CN1119156C Xiancaoteng capsule made korean epimedium herb, liquorice root and common threewingnut root and its preparation
08/27/2003CN1119080C Implantable agarose-collagen beads containing cells which produce a diffusible bilogical product, and uses thereof
08/26/2003US6610847 Tyrosine kinase inhibitors; immunosuppressants
08/26/2003US6610834 Human IgM antibodies to chemokine receptors
08/26/2003US6610833 Hybridoma cell line; immunoglobulins; can use in treating human immunodeficiency virus infections
08/26/2003US6610826 Cyclopeptide derivatives with integrin inhibitor properties
08/26/2003US6610820 Cell-permeable peptide inhibitors of the JNK signal transduction pathway
08/26/2003US6610745 Use of 2-hydroxy-4-trifluoromethyl-benzoic acid derivatives as inhibitors of the activation of the nuclear transcription factor NF-KS
08/26/2003US6610744 Methods of treatment with compounds having RARα receptor specific or selective activity
08/26/2003US6610742 Treatment of T-helper cell type 2-mediated immune diseases by retinoid antagonists
08/26/2003US6610737 Non-psychotropic cannabinoids
08/26/2003US6610715 Cathecol hydrazone derivatives, process for preparing the same and pharmaceutical composition containing the same
08/26/2003US6610711 4-phenylpiperidines for the treatment of pruritic dermatoses
08/26/2003US6610700 Inhibit binding of integrins to their ligands, use in immune or inflammatory disorders; 3-(4-((2,6-Naphthyridinyl)amino)-phenyl)-2-((2-(1-ethylpropyl)-3-oxo-1 -cyclopentenyl) amino)-propionic acid, for example
08/26/2003US6610697 Substituted 2-aryl-3-(heteroaryl)-imidazo[1,2-a]pyrimidines, and related pharmaceutical compositions and methods
08/26/2003US6610695 Prophylaxis or treatment of CSBP/RK/p38 kinase mediated disease
08/26/2003US6610688 For therapy of blood vessel proliferative disorders; fibrotic disorders; mesangial cell proliferative disorders; metabolic disorders; allergies; asthma; thrombosis; nervous system diseases; and cancer
08/26/2003US6610683 Treatment of infectious disease using interleukin-1β-converting enzyme (ICE)/CED-3 family inhibitors
08/26/2003US6610674 Method of treating inflammatory conditions with progesterone analogs
08/26/2003US6610661 Immunostimulatory polynucleotide/immunomodulatory molecule conjugates
08/26/2003US6610659 Use of heat shock protein 70 preparations in vaccination against cancer and infectious disease
08/26/2003US6610541 Recombinant, active caspases and uses thereof
08/26/2003US6610523 Human mitogen-activated (MAP) kinase kinase isoforms (MKKs). MKKs mediate unique signal transduction pathways that activate human MAP kinases p38 and JNK, which result in activation of other factors, including activating
08/26/2003US6610501 Porcine protein and uses thereof
08/26/2003US6610319 Immune response modifier compounds for treatment of TH2 mediated and related diseases
08/26/2003US6610308 Immunostimulant emulsion
08/26/2003US6610297 Compositions for treating allergies that include either BSW17 mimotope peptides or antibodies raised against BSW17 mimotope peptides. Also disclosed are methods for the treatment of allergies which involve administration of BSW17 mimeotope
08/26/2003US6610294 Methods of inhibiting an autoimmune response in a human suffering from an autoimmune disease by administering an antibody that binds to a protein to which monoclonal antibody 5C8 binds
08/26/2003US6610044 Method for genetic immunization
08/26/2003CA2220063C Acellular pertussis vaccines and methods of preparation thereof
08/21/2003WO2003068968A2 Mutated gene coding for a lat protein and the biological applications thereof
08/21/2003WO2003068954A2 Microorganism for genetic therapeutic treatment of proliferative diseases
08/21/2003WO2003068941A2 Modulation of immune response by non-peptide binding stress response polypeptides
08/21/2003WO2003068937A2 Embryonic-like stem cells derived from post-partum mammalian placenta and uses and methods of treatment using said cells
08/21/2003WO2003068822A2 De-immunized (poly)peptide constructs
08/21/2003WO2003068819A1 Method for the generation of genetically modified vertebrate precursor lymphocytes and use thereof for the production of heterologous binding proteins
08/21/2003WO2003068812A2 Immune-modulating peptide made of s. aureus enterotoxin b
08/21/2003WO2003068811A2 Cytotoxic t-cell epitopes from chlamydia
08/21/2003WO2003068803A2 A nucleic acid encoding a g-protein-coupled receptor, and uses thereof
08/21/2003WO2003068768A1 Imidazole 4-carboxamide compounds with adenosine deaminase inhibiting activity
08/21/2003WO2003068766A1 1-phenyl-2-heteroaryl-substituted benzimidazole derivatives, the use thereof for producing drugs used in the treatment of immunological diseases
08/21/2003WO2003068759A1 Piperazine derivatives as anti-inflammatory agents
08/21/2003WO2003068747A1 Nicotinamide derivates useful as p38 inhibitors
08/21/2003WO2003068744A1 Pyridine derivatives or salts thereof and cytokine production inhibitors containing the same
08/21/2003WO2003068743A1 Chemical compounds
08/21/2003WO2003068742A1 Synthesis of indole thiazole compounds as ligands for the ah receptor
08/21/2003WO2003068258A1 7s immunoglobulin for treatment of choroidal neovascularisation_
08/21/2003WO2003068250A1 Compositions and methods for treatment of skin disorders
08/21/2003WO2003068249A1 Shark cartilage extracts and use thereof for immunomodulation
08/21/2003WO2003068245A1 Use of polyanhydroglucuronic acid comprising microdispersed oxidised cellulose as immunomodulator
1 ... 693 694 695 696 697 698 699 700 701 702 703 704 705 706 707 708 709 710 711 712 713 ... 1172